J Appl Biomed 16:111-119, 2018 | DOI: 10.1016/j.jab.2017.11.002
Effect of pramipexole alginate nanodispersion (PAND) on the transgenic Drosophila expressing human alpha synuclein in the brain
- a Aligarh Muslim University, Faculty of Life Sciences, Department of Zoology, Section of Genetics, Drosophila Transgenic Laboratory, Aligarh, India
- b Aligarh Muslim University, Faculty of Science, Department of Physics, Aligarh, India
- c TERI-Deakin Nanobiotechnology Centre, TERI Gram, The Energy and Resources Institute, Gurgaon, Haryana, India
- d Aligarh Muslim University, Interdisciplinary Nanotechnology Centre, Aligarh, India
In the present study the effect of pramipexole alginate nanodispersion (PAND) was studied on the transgenic Drosophila exhibiting the PD symptoms. The PD flies were allowed to feed on the diet having PAND at final concentration of 1, 2 and 3 μM. A dose dependent significant delay in the loss of climbing ability and improvement in the activity was observed in PD flies. A dose dependent significant change in the oxidative stress markers and dopamine content was also observed in the PD flies exposed to various doses PAND. The improvement in the PD symptoms was more in PD flies exposed to PAND compared to PD flies exposed to pramipexole alone.
Keywords: Pramipexole; Parkinson's disease; Oxidative stress; Drosophila melanogaster; Nanocomposite
Received: December 27, 2016; Revised: October 5, 2017; Accepted: November 21, 2017; Published: May 1, 2018 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Alam, Z.I., Daniel, S.E., Lees, A.J., Marsden, D.C., 1997. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 1326-1329.
Go to original source...
Go to PubMed...
- Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M., Bonini, N.M., 2002. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868.
Go to original source...
Go to PubMed...
- Barnett-Cowan, M., Dyde, R.T., Fox, S.H., Moro, E., Hutchison, W.D., Harris, L.R., 2010. Multisensory determinants of orientation perception in Parkinson's disease. Neuroscience 167 (4), 1138-1150.
Go to original source...
Go to PubMed...
- Bayersdorfer, F., Voigt, A., Schneuwly, S., Botella, J.B., 2010. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiol. Dis. 40, 113-119.
Go to original source...
Go to PubMed...
- Botella, J.A., Bayersdorfer, F., Schneuwly, S., 2008. Superoxide dismutase over expression protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 30, 65-73.
Go to original source...
Go to PubMed...
- Brand, A.H., Perrimon, N., 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.
Go to original source...
Go to PubMed...
- Brusa, L., Pavino, V., Massimetti, M.C., Bove, R., Iani, C., Stanzione, P., 2013. The effect of dopamine agonists on cognitive functions in non-demented early-mild Parkinson's disease patients. Funct. Neurol. 28 (1), 13-17.
- Burdick, K.E., Braga, R.J., Nnadi, C.U., Shaya, Y., Stearns, W.H., Malhotra, A.K., 2011. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J. Clin. Psychiatry 73 (1), 103-112.
Go to original source...
Go to PubMed...
- Butler, E.K., Voigt, A., Lutz, A.K., Torgel, J.P., Gerhardt, E., Karsten, P., et al., 2012. The mitochondrial chaperone protein TRAP1 mitigates a-synuclein toxicity. PLoS Genet. 8 (2), e1002488.
Go to original source...
Go to PubMed...
- Carvey, P.M., Pieri, S., Ling, Z.D., 1997. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J. Neural Transm. 104 (2-3), 209-228.
Go to original source...
Go to PubMed...
- Castro-Hernandez, J., Afonso-Oramas, D., Cruz-Muros, I., Salas-Hernández, J., Barroso-Chinea, P., Moratalla, R., González-Hernández, T., 2015. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. Neurobiol. Dis. 74, 325-335.
Go to original source...
Go to PubMed...
- Cedarbaum, J.M., 1987. Clinical pharmacokinetics of anti-parkinsonian drugs. Clin. Pharmacokinet. 13, 141-178.
Go to original source...
Go to PubMed...
- Chiu, J.C., Low, K.H., Pike, D.H., Yildirim, E., Edery, I., 2010. Assaying locomotor activity to study circadian rhythms and sleep parameters in Drosophila. JoVE 43, e2157.
Go to original source...
Go to PubMed...
- Cookson, M.R., 2005. The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74, 29-52.
Go to original source...
Go to PubMed...
- Degim, I.T., Acarturk, F., Erdogan, D., Lorlar, N.D., 2003. Transdermal administration of bromocritine. Biol. Pharm. Bull. 26 (4), 501-505.
Go to original source...
Go to PubMed...
- Dreiseitel, A., Korte, G., Schreier, P., Oehme, A., Locher, S., Domani, M., Sand, P.G., 2009. Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol. Res. 59 (5), 306-311.
Go to original source...
Go to PubMed...
- Emsaki, G., Asgari, K., Molavi, H., Chitsaz, A., 2013. A comparison of the effectiveness of three drug regimens on cognitive performance of patients with Parkinson's disease. Psicologica: Int. J. Methodol. Exp. Psychol. 34 (2), 273-284.
- Fatima, A., Khanam, S., Rahul, R., Jyoti, S., Naz, F., Ali, F., Siddique, Y.H., 2017. Protective effect of tangeritin in transgenic Drosophila model of Parkinson's disease. Front. Biosci. 9, 44-53.
Go to original source...
Go to PubMed...
- Feany, M.B., Bender, W.W., 2000. A Drosophila model of Parkinson's disease. Nature 404, 394-398.
Go to original source...
Go to PubMed...
- Fujita, Y., Izawa, Y., Ali, N., Kanematsu, Y., Tsuchiya, K., Hamano, S., Yoshizumi, M., 2006. Pramipexole protects against H2O2-induced PC12 cell death. NaunynSchmiedeberg's Arch. Pharmacol. 372 (4), 257-266.
Go to original source...
Go to PubMed...
- Gallant, H., Vo, A., Seergobin, K.N., MacDonald, P.A., 2016. Pramipexole impairs stimulus-response learning in healthy young adults. Front. Neurosci. 10, 374.
Go to original source...
Go to PubMed...
- Gesualdi, N.M., Chirico, G., Pirozzi, G., Costantino, E., Landriscina, M., Esposito, F., 2007. Tumour necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10 (4), 342-350.
Go to original source...
Go to PubMed...
- Giasson, B.I., Duda, J.E., Murray, I.V., Chen, Q., Souza, J.M., Hurtig, H.I., Lee, V.M.Y., 2000. Oxidative damage linked to neurodegeneration by selective a-synuclein nitration in synucleinopathy lesions. Science 290 (5493), 985-989.
Go to original source...
Go to PubMed...
- Gu, M., Iravani, M.M., Cooper, J.M., King, D., Jenner, P., Schapira, A.H., 2005. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J. Neurochem. 92 (1), 215.
Go to original source...
- Guo, M., 2012. Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, 1-17.
Go to original source...
Go to PubMed...
- Habig, W.H., Pabst, M.J., Fleischner, G., Gatmaitan, Z., Arias, I.M., Jakoby, W.B., 1974. The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc. Natl. Acad. Sci. 71 (10), 3879-3882.
Go to original source...
Go to PubMed...
- Hawkins, C.L., Morgan, P.E., Davies, M.J., 2009. Quantification of protein modification by oxidants. Free Radic. Biol. Med. 46 (8), 965-988.
Go to original source...
Go to PubMed...
- Hong, C., Sun, Y., Lu, C., 2008. Fatal intoxication using amantadine and pramipexole in a uremic patient. Acta Neurol. Taiwan. 17 (2), 109-111.
Go to PubMed...
- Iravani, M.M., Haddon, C.O., Cooper, J.M., Jenner, P., Schapira, A.H., 2006. Pramipexole protects against MPTP toxicity in non-human primates. J. Neurochem. 96 (5), 1315-1321.
Go to original source...
Go to PubMed...
- Izumi, Y., Sawada, H., Yamamoto, N., Kume, T., Katsuki, H., Shimohama, S., Akaike, A., 2007. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. Eur. J. Pharmacol. 557 (2), 132-140.
Go to original source...
Go to PubMed...
- Johnson, W.M., Wilson-Delfosse, A.L., Mieyal, J.J., 2012. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 4, 1399-1440.
Go to original source...
Go to PubMed...
- Jollow, D.J., Mitchell, J.R., Zampaglione, N.A., Gillette, J.R., 1974. Bromobenzeneinduced liver necrosis. Protective role of glutathione and evidence for 3, 4bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11 (3), 151- 169.
Go to original source...
Go to PubMed...
- Lee, W.H., Loo, C.Y., Bebawy, M., Luk, F., Mason, R.S., Rohanizadeh, R., 2013. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21 st century. Curr. Neuropharmacol. 11 (4), 338-378.
Go to original source...
Go to PubMed...
- Leyva-Gómez, G., Cortés, H., Magaña, J.J., Leyva-García, N., Quintanar-Guerrero, D., Florán, B., 2015. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain. Drug Discov. Today 20 (7), 824-837.
Go to original source...
Go to PubMed...
- Masuda, Y., Shima, G., Aiuchi, T., Horie, M., Hori, K., Nakajo, S., Nakaya, K., 2004. Involvement of tumour necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by I-hydroxyisovalerylshikonin. J. Biol. Chem. 279, 42503- 42515.
Go to original source...
Go to PubMed...
- Mazzio, E.A., Harris, N., Soliman, K.F., 1998. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med. 64 (07), 603-606.
Go to original source...
Go to PubMed...
- McEwen, C.M., 1965. Human plasma monoamine oxidase I. Purification and identification. J. Biol. Chem. 240 (5), 2003-2010.
Go to original source...
- Muñoz-Soriano, V., Paricio, N., 2011. Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies. Parkinson's Dis. 2011, 1-14.
Go to original source...
- Mukhopadhyay, I., Saxena, D.K., Chowdhuri, D.K., 2003. Hazardous effects of effluent from the chrome plating industry: 70 kDa heat shock protein expression as a marker of cellular damage in transgenic Drosophila melanogaster (hsp70-lacZ). Environ. Health Perspect. 111 (16), 1926-1932.
Go to original source...
Go to PubMed...
- Naoi, M., Maruyama, W., 2010. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders. Curr. Pharm. Des. 16, 2799-2817.
Go to original source...
Go to PubMed...
- Ohkawa, H., Nobuko, O., Yagi, K., 1978. Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J. Lipid Res. 19, 1053-1057.
Go to original source...
Go to PubMed...
- Pandey, U.B., Nichols, C.D., 2011. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev. 63 (2), 411- 436.
Go to original source...
Go to PubMed...
- Papadimitriou, S., Bikiaris, D., Avgoustakis, K., Karavas, E., Georgarakis, M., 2008. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr. Polym. 73, 44-54.
Go to original source...
- Patterson, T.A., Li, M., Hotchkiss, C.E., Mauz, A., Eddie, M., Greischel, A., Paule, M.G., 2010. Toxicity assessment of pramipexole in juvenile rhesus monkeys. Toxicology 276 (3), 164-171.
Go to original source...
Go to PubMed...
- Peluffo, H., Unzueta, U., Negro-Demontel, M.L., Xu, Z., Váquez, E., Ferrer-Miralles, N., Villaverde, A., 2015. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS. Biotechnol. Adv. 33 (2), 277-287.
Go to original source...
Go to PubMed...
- Pendleton, R.G., Parvez, F., Sayed, M., Hillman, R., 2002. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J. Pharmacol. Exp. Ther. 300 (1), 91-96.
Go to original source...
Go to PubMed...
- Poletti, M., Bonuccelli, U., 2013. Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review. Therap. Adv. Psychopharmacol. 3 (2), 101-113.
Go to original source...
Go to PubMed...
- Ramirez, A.D., Wong, S.K.F., Menniti, F.S., 2003. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur. J. Pharmacol. 475 (1), 29-35.
Go to original source...
Go to PubMed...
- Rasmussen, V.G., Østergaard, K., Dupont, E., Poulsen, S.H., 2011. The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists. Mov. Disord. 26, 801-806.
Go to original source...
Go to PubMed...
- Rektorová, I., Rektor, I., Bareš, M., Dostál, V., Ehler, E., Fanfrdlová, Z., Svátová, J., 2003. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur. J. Neurol. 10 (4), 399-406.
Go to original source...
Go to PubMed...
- Riederer, P., Laux, G., 2011. MAO-inhibitors in Parkinson's disease. Exp. Neurobiol. 20 (1), 1-17.
Go to original source...
Go to PubMed...
- Riemensperger, T., Issa, A.R., Pech, U., Coulom, H., Nguyễn, M.V., Cassar, M., Birman, S., 2013. A single dopamine pathway underlies progressive locomotor deficits in a Drosophila model of Parkinson disease. Cell Rep. 5, 952-960.
Go to original source...
Go to PubMed...
- Rosato, E., Kyriacou, C.P., 2006. Analysis of locomotor activity rhythms in Drosophila. Nat. Protoc. 1 (2), 559-568.
Go to original source...
Go to PubMed...
- Schlumpf, M., Lichtensteiger, W., Langemann, H., Waser, P.G., Hefti, F., 1974. A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem. Pharmacol. 23 (17), 2437-2446.
Go to original source...
Go to PubMed...
- Schulz, J.B., 2007. Mechanisms of neurodegeneration in idiopathic Parkinson's disease. Parkinsonism Relat. Disord. 13, S306-S308.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Ara, G., Jyoti, S., Afzal, M., 2011. The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease. J. Diet. Suppl. 9, 1-8.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Ara, G., Jyoti, S., Afzal, M., 2012. Protective effect of curcumin in transgenic Drosophila melanogaster model of Parkinson's disease. Altern. Med. Stud. 2 (1), 3.
Go to original source...
- Siddique, Y.H., Fatima, A., Jyoti, S., Naz, F., Khan, W., Singh, B.R., Naqvi, A.H., 2013a. Evaluation of the toxic potential of graphene copper nanocomposite (GCNC) in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ) Bg 9. PLoS One 8 (12), e80944.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Mujtaba, S.F., Jyoti, S., Naz, F., 2013b. GC-MS analysis of Eucalyptus citriodora leaf extract and its role on the dietary supplementation in transgenic Drosophila model of Parkinson's disease. Food Chem. Toxicol. 55, 29-35.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Naz, F., Jyoti, S., Fatima, A., Khanam, S., Ali, F., et al., 2014. Effect of Centella asiatica leaf extract on the dietary supplementation in transgenic Drosophila model of Parkinson's disease. Parkinson's Dis. 2014, 262058. doi: http://dx.doi.org/10.1155/2014/262058.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Haidari, M., Khan, W., Fatima, A., Jyoti, S., Khanam, S., Beg, T., 2015. Toxic potential of copper-doped ZnO nanoparticles in Drosophila melanogaster (Oregon R). Toxicol. Mech. Methods 25 (6), 425-432.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Naz, F., Jyoti, S., Ali, F., Fatima, A., Khanam, S., 2016a. Protective effect of Geraniol on the transgenic Drosophila model of Parkinson's disease. Environ. Toxicol. Pharmacol. 43, 225-231.
Go to original source...
Go to PubMed...
- Siddique, Y.H., Khan, W., Fatima, A., Jyoti, S., Khanam, S., Naz, F., Naqvi, A.H., 2016b. Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease. Dis. Models Mech. 9 (1), 63-68.
Go to original source...
Go to PubMed...
- Szczudlik, A., Rudzin ska, M., 2006. Neuroprotective effect of dopamine agonists. Neurol. Neurochir. Pol. 41 (2 Suppl. 1), S22-S28.
- Tan, L.C.S., Ng, K.K.C., Au, W.L., Lee, R.K.K., Chan, Y.H., Tan, N.C.K., 2009. Bromocriptine use and the risk of valvular heart disease. Mov. Disord. 24, 344- 349.
Go to original source...
Go to PubMed...
- Yang, H., 2010. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm. Res. 27 (9), 1759-1771.
Go to original source...
Go to PubMed...
- Zhu, Y., Carvey, P.M., Ling, Z., 2007. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem. Int. 50 (4), 671-680.
Go to original source...
Go to PubMed...
- Zou, L.L., Xu, J., Jankovic, J., He, Y., Appel, S.H., Le, W.D., 2000. Pramipexole inhibits lipid peroxidation and reduces injury in the substantianigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57BL/6 mice. Neurosci. Lett. 281 (2), 167-170.
Go to original source...
Go to PubMed...